A retrospective case-control study evaluating efficacy of citicoline plus rivastigmine in patients with in Alzheimer's disease and mixed dementia.
Latest Information Update: 21 Oct 2016
At a glance
- Drugs Citicoline (Primary) ; Rivastigmine (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Therapeutic Use
- Acronyms CITIRIVAD
- 21 Oct 2016 New trial record
- 01 Sep 2016 Results published in the Clinical Drug Investigation